Characterisation of a synergistic interaction between a thymidylate synthase inhibitor, ZD1694, and a novel lipophilic topoisomerase I inhibitor karenitecin, BNP1100: mechanisms and clinical implications-Reference-Cited by-同舟云学术

Characterisation of a synergistic interaction between a thymidylate synthase inhibitor, ZD1694, and a novel lipophilic topoisomerase I inhibitor karenitecin, BNP1100: mechanisms and clinical implications

Published:1999-06 Issue:6 Volume:35 Page:984-993
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Matsui S.-i,Endo W,Wrzosek C,Haridas K,Seetharamulu P,Hausheer F.H,Rustum Y.M

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference63 articles.

1. Cohen AM, Minsky BD, Schilsky RL. Cancer of colon. In DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles & Practice of Oncology, 5th edn. Philadelphia and New York, Lippincott-Raven, 1144–1234.

2. Thymidylate synthase inhibitors in cancer therapy: direct and indirect inhibitors;Rustum;J. Clin. Oncol.,1997

3. Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Study;Leichman;J. Clin. Oncol.,1995

4. Enhanced 5-fluorouracil nucleotide formation after methotrexate administration: explanation for drug synergism;Cadman;Science,1970

5. Lokich J, Cantrell J, Ahlgren J, Phillips J for the Mid-Atlantic Oncology Program (MAOP). A phase III trial of protracted infusional 5FU (PIF) versus PIF plus weekly bolus cisplatin (CDDP) in advanced measurable colon cancer (MAOP protocol 5286). Proc Am Soc Clin Oncol 1988, 8, 104.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 3,7-bis-benzylidene hydrazide ciprofloxacin derivatives as promising antiproliferative dual TOP I & TOP II isomerases inhibitors;Bioorganic Chemistry;2021-05

2. Silicon-containing analogs of camptothecin as anticancer agents;Archiv der Pharmazie;2017-12-14

3. Novel N-4-piperazinyl-ciprofloxacin-chalcone hybrids: Synthesis, physicochemical properties, anticancer and topoisomerase I and II inhibitory activity;European Journal of Medicinal Chemistry;2013-11

4. In Vitro Antitumor Activity of 9-Nitro-Camptothecin as a Single Agent and in Combination with other Antitumor Drugs;Annals of the New York Academy of Sciences;2006-01-25

5. Camptothecin analogs with enhanced activity against human breast cancer cells. I. Correlation of potency with lipophilicity and persistence in the cleavage complex;Cancer Chemotherapy and Pharmacology;2005-08-23